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Abstract
We have shown previously that downregulation of intercaruncular stromal integrin αvβ3 in bovine
endometrium on day 16 of the estrous cycle coincided with the antibody recognition of estrogen
receptors (ER) in the luminal epithelium. In pregnancy, these changes were not observed. Our
hypothesis was that on day 16 of the estrous cycle, estrogen from the dominant follicle causes a
reduction in integrin αvβ3 and affects ERα in the luminal epithelium. The pregnancy recognition
protein, interferon-τ (IFN-τ), may prevent downregulation of integrin αvβ3 and suppress ERα
expression in the luminal epithelium. On days 14 to 16, heifers received uterine infusions of the
anti-estrogen ICI 182, 780, estradiol 17β, IFN-τ or the saline control. On day 16, reproductive
tracts were collected for analysis of integrin αvβ3 and ERα. Estrogen receptor α immunoreactivity
was largely restricted to the luminal epithelium in control animals. Using anti-ERα recognizing the
amino terminus, estrogen-treated animals showed reactivity in the stroma, shallow and deep glands
and myometrium as is typical of estrus, whereas ICI 182, 870 treated heifers showed little or no
reactivity. In contrast, carboxyl terminus-directed antibodies showed a widespread distribution of
ERα with reactivity detected in the uterine epithelium, stroma and myometrium of both estrogen
and ICI 182, 780 treated animals. Heifers treated with IFN-τ had low ERα reactivity overall.
Control and IFN-τ treated heifers had lower intercaruncular stromal expression of integrin αvβ3
in comparison to estrogen and ICI 182, 780 treatments. Overall, the results suggest that on day 16
of the estrous cycle, estrogen effects on integrin αvβ3 are indirect and do not directly involve ERα
in the luminal epithelium. During pregnancy, interferon-tau may block ERα in the luminal epithelium
but likely does not rescue integrin αvβ3 expression.
Introduction
Day 16 of the bovine estrous cycle is critical as it is the last
day for embryo transfer and marks the generation of the
luteolytic signal in the absence of a viable conceptus [1,2].
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We have identified two potential molecular markers of the
day 16 uterine environment: the adhesion and signalling
molecule, integrin αvβ3 and the estrogen receptor (ER)
[3,4]. Integrins are transmembrane heterodimers that fa-
cilitate cell-cell and cell-extracellular matrix attachment.
In doing so, integrins influence differentiation states of
the cells on which they are expressed and adjacent cells
through bi-directional signalling to and from the cell and
its environment [5]. In many species including cattle, in-
tegrin αvβ3 is present at the fetomaternal interface during
embryo attachment and implantation [6–10].
In comparison to other domestic animals [7,9], preferen-
tial expression of integrin αvβ3 in intercaruncular stromal
endometrium is unique to cattle [3]. There is little expres-
sion in luminal epithelium and the stroma of the carun-
cles, the endometrial sites where the maternal component
of the placenta will develop. Its expression is strongest in
the periluminal stroma in cells in contact with the basal
lamina of luminal epithelium. Downregulation of in-
tegrin αvβ3 in subepithelial stroma occurs on day 16 of the
estrous cycle, but not pregnancy [3,10]. This downregula-
tion coincides with a transient change in the ER in the lu-
minal epithelium and the onset of luteolysis [4]. In
support of a role for estrogens in regulating integrin αvβ3
expression in cyclic endometrium, downregulation of the
rate limiting integrin subunit β3 expression by estrogen is
reported in cultured endometrial cells [11–13].
The proposed sequence of hormonal and molecular
events leading to luteolysis involves positive feedback be-
tween the endometrium and ovary [2,14]. The role of es-
trogens and their receptors in initiation of luteolysis is not
yet clear, but exogenous estrogen stimulates luteal regres-
sion [15,16]. Studies in sheep suggest that upregulated ER
and oxytocin receptor expression in the luminal epitheli-
um are essential for initiation of luteolysis [17,18]. Dur-
ing ovine pregnancy, conceptus secreted interferon tau
(IFN-τ) is thought to block upregulation of ERα and oxy-
tocin receptor expression in the luminal epithelium,
which in turn suppresses luteolysis [18,19]. In cattle, the
effects of IFN-τ on ERα in the luminal epithelium at ma-
ternal recognition of pregnancy are unknown. There are
reported differences in the uterine location and timing of
ERα expression between sheep and cows, and among re-
search groups [4,17,20]. There are no reports of ERβ local-
ization in mature bovine endometrium, although our
preliminary unpublished observations using anti-human
ERβ indicate that it is present in association with blood
vessel walls but is not detectable in other endometrial
cells. Using an antibody that localized ERα (clone ID5),
Robinson et al. [20] detected ERα protein in the bovine
uterine luminal epithelium at levels ranging from low to
undetectable throughout the estrous cycle and pregnancy.
Using a different ERα antibody (clone AER314) we detect-
ed strong staining for ERα in the uterine luminal epitheli-
um only on day 16 of the estrous cycle and not in
endometrium from pregnant cows [4]. The antibodies
used in these bovine studies recognise different domains
of the ERα, which have been shown previously to affect
immunohistochemical reactivity in the luminal epitheli-
um [21].
The anti-estrogen ICI 182, 780 is classified as a pure anti-
estrogen due to its lack of estrogen-like activity [22,23].
ICI 182,780 acts by binding ER, which causes disassocia-
tion of receptor associated proteins and results in im-
paired receptor dimerisation and increased receptor
degradation [22,23]. In utero ICI 182, 780 blocks the
trophic action of estrogen in rodents, women and pigs
[23,24]. The effects of ICI 182, 780 in bovine endometri-
um have not yet been tested.
Our objectives were to investigate the effects of estrogen,
the antiestrogen ICI 182, 780 and IFN-τ on the expression
of ERα and integrin αvβ3 in bovine endometrium at the
time of maternal recognition of pregnancy. We hypothe-
sized that 1) IFN-τ alters expression of ERα in the luminal
epithelium and prevents downregulation of integrin αvβ3
on day 16 of pregnancy and, 2) estrogen acting via ERα in
the luminal epithelium causes downregulation of integrin
αvβ3 in the subepithelial stroma on day 16 of the estrous
cycle.
Materials and Methods
Animals
This study was performed using 12 beef heifers of mixed
breeds of similar age and weight (1.5–2 years; 520 ± 31
kg) and exhibiting estrous cycles of 18–20 days. Heifers
were checked for estrus twice daily throughout the experi-
ment and trained for tie stalls one month prior to uterine
infusions to adjust them to handling and confinement.
Animals were synchronized to estrus using Estrumate
(500 µg cloprostenol, Schering Canada Inc., QC, Cana-
da), according to the synchronization schedule shown in
Figure 1. All procedures performed were in accordance
with the guidelines of the Canadian Council on Animal
Care and were reviewed and approved by the Nova Scotia
Agricultural College Animal Care and Use Committee.
Treatments
Following induced estrus, 3 heifers per treatment were
randomly assigned to receive uterine infusion of a control
solution (0.1% BSA in saline), or estradiol-17β (117 ng/
dose; Sigma, Saint Louis, MO), or ICI 182, 780 (3 mg/
dose, Tocris, Avonmouth, Bristol, United Kingdom) or re-
combinant ovine IFN-τ (0.25 mg/dose = biological activi-
ty of 5 × 107 antiviral units/day; kindly provided by Drs.
T. E. Spencer and F.W. Bazer, Texas A & M University, Col-
lege Station, TX), from days 14 to 16 of the estrous cycle.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/38
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The dose of estradiol was based on physiological levels,
where the maximal venous-arterial difference in estradiol-
17β was multiplied by the average daily uterine arterial
blood flow measured for cows on days 13–17 of the es-
trous cycle [25]. The dose used for ICI 182, 780 was based
on an effective mg/kg dose administered to sheep via in-
trauterine infusion [26]. The dose for IFN-τ was selected
based on previous studies in sheep [18] and increased to
account for the greater uterine size of cows. Recombinant
ovine IFN-τ has been shown to be as effective as recom-
binant bovine IFN-τ in preventing luteolysis [27]. Treat-
ments were delivered every 12 h beginning at 6 pm on
cycle day 14 via intrauterine infusion of both horns using
12 gauge Foley® catheters (Agtech, Manhattan, KS), which
were positioned immediately anterior to the cervix prior
to delivery of the 5 ml treatment volume. Treatment
schedules are shown in Figure 1. At the time of treatment,
the horns were gently massaged to ensure even distribu-
tion throughout the uterus. Volume and delivery mecha-
nism were optimized prior to the experiment using
reproductive tracts obtained from the local abattoir and in
vivo using cull heifers.
Tissue Collection
Uteri were collected within 30 min postmortem and mor-
phological observations were made on the ovaries and re-
productive tract. Data on ovarian morphology according
to the methods of Ireland [28] were recorded to confirm
cycle stage. For each heifer uterine, cervical and corpus lu-
teum weight and length were recorded. Transverse sec-
tions 1 cm3  were dissected from the uterine horn
ipsilateral to the corpus luteum and snap frozen in liquid
nitrogen and stored at -80°C prior to preparation of cryo-
stat cross-sections for immunohistochemical analysis. In-
tercaruncular endometrium was dissected from the
ipsilateral horn, and snap frozen in liquid nitrogen for use
in mRNA analysis. Caruncular tissue was not used for
analysis of integrin αvβ3 since our previous work showed
low expression in the caruncles regardless of the day of the
cycle or pregnancy state [3,10].
Immunohistochemistry
Integrin αvβ3 and ERα protein were localized as previous-
ly described [3,4]. Briefly, 5–10 µm cryostat cross sections
of endometrium were placed on Superfrost Plus slides
(Fisher Scientific, Whitby, ON, Canada), air dried for 30
minutes, then fixed in acetone for 10 min and allowed to
air-dry overnight before long-term storage at -80 C. Sec-
tions were rehydrated in PBS, blocked in 2% BSA in PBS
and incubated with the monoclonal anti-αvβ3 from No-
vus Biologicals (clone BV4, Littleton, CO), a monclonal
antibody to the amino terminus of the ERα (ER Ab-1,
clone AER314 Neomarkers Inc., Union city, CA, USA) or
to the carboxy terminus of the ERα (ER Ab-8, clone
Figure 1
Synchronization schedule, heat detection and treatment regimes for heifers used in the study. Heifers were injected with 
Estrumate® 11 days apart and observed for heats after the second injection. All heifers were observed in standing heat within 
the same twelve hour period then observed for one cycle length of 18–20 days. Twelve days after non-induced estrus, heifers 
were injected a third time and observed for heats. At 6 pm, fourteen days following standing heat treatment began. Heifers 
received four uterine infusions 12 hr apart of either saline control, IFN-τ, estrogen or ICI 182,780. At 2 pm on day 16 of the 
estrous cycle, heifers were slaughtered and tissues were collected for analysis.
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AER314), or the control, purified mouse IgG (Chemicon)
for 2 h. Sections were then washed and incubated with
biotinylated horse-anti-mouse secondary (Vector Labora-
tories, Burlingame, CA) for 30 min. Immunoreactivity
was visualized using a fluorochrome conjugated streptavi-
din probe (Alexa-488, Molecular Probes, Inc., Eugene,
OR, USA). Immunohistochemistry experiments were re-
peated on different days using tissue sections from all an-
imals on each day. To determine effects of treatment on
levels of integrin αvβ3 protein in uterine tissue, signal in-
tensity of the intercaruncular subepithelial stroma was
scored by two observers on a six-point scale (0-negative, 1-
very weak, 2-weak but clearly positive, 3-intermediate, 4-
high, and 5-very high). Four slides from each heifer were
scored.
Northern Blotting
Total RNA was extracted from intercaruncular endometri-
um using Trizol™ reagent (Life Technologies, Burlington,
ON, Canada). Thirty five µg of total RNA was electro-
phoresed in denaturing 1.2% agarose, 2.2 M formalde-
hyde gels in 1X morpholinepropanesulfonic acid (MOPS,
0.02 M, pH 7.0, 2 mM sodium acetate, 1 mM EDTA pH
8.0) with appropriate markers for 2 h at 8 V/cm. Gels were
blotted onto a positively charged nylon membrane (Ro-
che Molecular Biochemicals, Laval, QC, Canada) using
downward capillary transfer in alkaline buffer for 1 h. Two
probing methods were used for two separate northern
blots each with samples from each of the 12 animals. For
the first blot, biotin labeled riboprobes were prepared via
in vitro transcription (Roche). Blots were prehybridized in
Ultrahyb™ (Ambion Inc, Austin, TX, USA) at 65 C for 30
min prior to the addition of the riboprobe. The blot was
probed overnight at 65 C, and then washed at 65 C, 3
times for 20 min in 2X SSC/0.1% SDS (1X SSC = 150 mM
sodium chloride and 15 mM sodium citrate pH 7.0). Hy-
bridized probe was detected using chemiluminescence's
performed according to the North2South™ kit protocol
(Pierce Chemical Company, Rockford, IL). For the second
blot,  32P-labeled riboprobes were prepared via in vitro
transcription and membrane was prehybridized at 68 C
for 30 min, followed by overnight hybridization in Ult-
rahyb™ at 68 C in the presence of 1 × 106 cpm probe/ml.
After hybridization the membrane was washed at room
temperature in 2X SSC/0.1% SDS (1X SSC = 150 mM so-
dium chloride and 15 mM sodium citrate pH 7.0) two
times for 5 min each, followed by 2 washes at 68 C in
0.25X SSC/0.1% SDS for 15 min each. After washing the
membrane was exposed to x-ray film using an intensifying
screen at -80 C for three days. Intensity of integrin subunit
αvβ3 mRNA and 18S rRNA bands were measured using
the Gene Genius Bioimaging System (Fisher Scientific). As
indicated above, Northern blots were repeated once so
there were six observations per treatment (3 animals × 2
blots).
Data Expression and Statistical Analysis
Data were checked for normality using the univariate pro-
cedure in SAS™ (Statistical Analysis Software Version 8,
SAS Institute Inc., Cary, NC) and analyzed using the gen-
eral linear models procedure to examine the effect of treat-
ment on reproductive tract measurements, integrin αvβ3
protein immunohistochemical score, and integrin subu-
nit αvβ3 mRNA. Day of experiment and day by treatment
interactions were included in the immunohistochemistry
and Northern blot analyses, although interactions were
not significant. For northern blots, intensity of the 18S
band within blot was included as a covariate to account
for loading differences. Least squares means were com-
pared using the Tukey-Kramer test. The selected α error
rate was P ≤ 0.05.
Results
Effects of Treatment on Uterine Characteristics
From visual examination all uteri were similar among
treatments in terms of size, tone or color. Although not
statistically significant there was a tendency for heavier
uterine weights from estrogen-treated heifers (P = 0.10).
No differences were observed between uterine, cervical or
corpus luteum measurements of weight and length (P >
0.05). Gross uterine observations are summarized in Ta-
ble 1.
Table 1: Reproductive tract characteristics of heifers treated with interferon-tau (IFN-τ), estrogen or ICI 182, 780.
Treatment Uterine Weight (g) Uterine Length (cm) Cervix Length (cm) Corpus Luteum Weight (g)
Control 171 ± 6 23 ± 3 9 ± 3 5 ± 0.4
IFN-τ 187 ± 8 23 ± 4 8 ± 1 5 ± 0.4
Estrogen 275 ± 19 25 ± 7 8 ± 1 4 ± 1
ICI 182,780 189 ± 43 22 ± 3 7 ± 1 5 ± 1
Mean ± standard errorReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/38
Page 5 of 10
(page number not for citation purposes)
Effect of Treatment on Uterine Distribution of the Estro-
gen Receptor-α
Reactivity to ERα antibodies (AER314 and AER 311) was
used to measure the effects of treatments. Immunofluo-
rescent reactivity in the luminal epithelium was present in
sections from control heifers using both AER314 (Fig. 2A)
and AER311 (Fig. 2B), and a small proportion of stromal
cells showed nuclear reactivity (Fig. 2A,2B, arrows). In
some animals, there was reactivity in the glands (data not
shown). In sections from heifers infused with IFN-τ, reac-
tivities to AER314 and AER311 were low in comparison to
control animals (Fig. 2C,2D). There was no reactivity in
the luminal epithelium. In some animals, there was nu-
clear staining in the glandular epithelium of some sec-
tions (data not shown). In sections from ICI 182, 780
treated animals, there was little or no specific immunoflu-
orescence was detected throughout the endometrium us-
ing antibody AER314 (Fig. 2G). In contrast, strong
immunofluorescent signals were present in the nuclei of
glands, stroma and luminal epithelium in sections from
ICI 182, 780 treated animals using antibody AER311 (Fig.
2H). Estrogen treated heifers showed strong reactivity to
both antibodies AER314 and AER311 in the nuclei of stro-
ma, glandular epithelium and myometrium (Fig. 2E,2F),
but only in the luminal epithelium using antibody
AER311 (Fig. 2F).
Effect of Treatment on Uterine Distribution of Integrin 
αvβ3
For all treatments, integrin αvβ3 expression was detected
in the stroma (Fig. 3A), myometrium and arteriolar
smooth muscle (data not shown). In tissue sections from
all animals, reactivity was low in the caruncles (eg., ICI
182, 780 panel of Fig. 3). Intense reactivity was observed
in sections from estrogen and ICI 182, 780 treated heifers
on stromal cells in close proximity to the basement mem-
brane of the luminal epithelium of intercaruncular en-
dometrium (Fig 3A, arrows). Accordingly, sections from
ICI 182,780 and estrogen treated heifers had higher scores
for subepithelial stromal cell staining than control or IFN-
τ treated animals (P < 0.05) (Fig. 3B).
Effect of Treatment on Expression of Integrin Subunit β3 
mRNA
Northern blot analysis revealed a single 2.4 kb transcript
for bovine integrin subunit β3 corresponding to the pub-
lished coding sequence of 2.364 kb [29]. In intercaruncu-
lar tissue samples levels of integrin subunit β3 transcript
were lowest from heifers infused with control solution
and IFN-τ in comparison to tissue from estrogen and ICI
182,780 treated heifers (P < 0.05) (Fig. 4).
Discussion
This is the first study to test the anti-estrogen ICI 182, 780
in the bovine uterus. No differences in uterine morpholo-
gy were observed between treatments, which is not unex-
pected given the short exposure period, although estrogen
but not ICI 182, 780 treated heifers tended to have heavier
uterine weights. Unexpectedly, expression of ERα was
readily detected in the luminal epithelium, stroma and
glandular epithelium of sections from ICI 182, 780 treat-
ed heifers using antibody AER311. The distribution was
similar to that observed in the estrogen-treated heifers
with this antibody. Previous studies have shown that high
levels of estrogen, such as those observed at estrus, are as-
sociated with this pattern of ERα expression [4,20,30].
Since ERα distribution did not differ between estrogen
and ICI 182, 780 treated heifers and did differ from con-
trols, ICI 182, 780 showed agonist, rather than antagonist,
activity towards the bovine estrogen receptor. Interesting-
ly, the reactivity to antibody AER314 was reduced in ICI
182, 780 but not estrogen treated animals, indicating that
the effects of the two compounds are distinct. This may ex-
plain the lack of ICI 182, 780 effect on uterine morpholo-
gy. In bovine endometrial explants, ICI 182, 780 was
antagonistic to estrogen [31]. The reported mode of action
of ICI 182, 780 is to disrupt translocation of receptors to
the nucleus and increase receptor degradation [22,23], so
a decline in ERα reactivity was expected regardless of anti-
body used. In the ewe, endometrial expression of ERα was
lower in ICI 182, 780 treated than estrogen treated ani-
mals [26]. However similar to results presented here, in
that species the ICI 182, 780 also showed partial agonist
effects as evidenced by increased uterine weights, and
GAPDH mRNA expression that did not differ from estro-
gen treated ewes [26].
Schuler et al. [21] localized ERα in bovine placentomes
using four antibodies to ERα. Two of the antibodies recog-
nized the carboxy terminus and positively reacted with
maternal luminal epithelium, while the two amino termi-
nal targeting antibodies did not. The current study is con-
sistent with this pattern. The amino terminus of the ERα
contains the AF-1 domain that undergoes a conforma-
tional change when the receptor is bound by estrogen and
its activity is regulated by growth factors [22,32]. It is in-
teresting that this antibody recognizes ERα in the luminal
epithelium only in endometrium from calves [21], day 16
of the estrous cycle but not in tissues from other days of
the estrous cycle [4], from pregnant cattle [4,21], or in en-
dometrium from ICI 182,780 treated animals. The chang-
es in AER314 binding may reflect changes in epitope
accessibility related to a different functional conformation
of the ERα. Possible causes include changes in receptor
phosphorylation, estrogen binding, and/or in ERα cofac-
tor association [22,32]. Impaired cofactor association is a
reported mechanism of action of ICI 182,780 [22,23],
thus it is conceivable that there was some antagonistic ac-
tivity of the compound in the current study, which result-
ed in reduced recognition of the ERα by antibodyReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/38
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Figure 2
Immunofluorescent localization of the estrogen receptor using antibodies AER314 and AER311 in cyrostat cross-sections of 
endometrium obtained on day 16 of the estrous cycle after uterine infusion with a BSA-saline control solution (A-B), inter-
feron-tau (C-D), ICI 182, 780 (E-F) or estrogen (G-H). A tissue section treated with mouse IgG in place of primary antibody 
is shown inset in A. Specific nuclear reactivity was present in some cells of the stroma (arrows) in control animals. LE – luminal 
epithelium, S – stroma, GE – glandular epithelium. Magnification for A-C was 400X, D,F,H was 200X and E,G 100X.
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Figure 3
Immunofluorescent analysis of integrin αvβ3 in cryostat cross-sections of endometrium. (A) Immunoreactivity in sections from 
heifers treated with control solution, interferon-tau (IFN-τ), estrogen or ICI 182, 780. Diffuse staining was present in the dense 
stroma, low reactivity was observed in the glands (GE) and luminal epithelium (LE). Note the strong reactivity of intercaruncu-
lar subepithelial stromal cells (arrows) in sections from estrogen and ICI 182, 780 treated animals. CARS – caruncular stroma; 
ICS – intercaruncular stroma. Magnification was 100X. B) Least squares means ± standard error of signal intensity of integrin 
αvβ3 in the subepithelial stroma (SES) by treatment (3 animals × 4 replicate experiments per treatment). Intensity was scored 
on a six point scale (0-negative, 1-very weak, 2-weak but clearly positive, 3-intermediate, 4-high, and 5-very high) and the data 
were subjected to ANOVA and the Tukey-Kramer multiple comparison of means to determine effects of treatment in com-
parison to the control. Asterisks indicate means that are significantly different from the control (P < 0.05).
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AER314. Early postnatal calf uterine epithelium would be
in a continued state of differentiation that is likely to re-
quire functional ERα [34], consistent with AER314 recog-
nition of a functional form of the receptor. To summarize,
the results indicate that the AER314 antibody recognizes a
temporary change in the ERα, and may be used to detect
altered ERα conformation as an early marker of the onset
of luteolysis.
In sheep, IFN-τ blocks ERα transcription in the luminal
epithelium by stimulating binding of IFN regulatory fac-
tor 1 to interferon stimulated response elements on the
ERα gene [19,35,36]. This action of IFN-τ is thought to
prevent ERα expression and the onset of luteolysis. Estro-
gen receptor mRNA and protein are present in the luminal
epithelium on day 16 of bovine pregnancy, although lev-
els may be reduced [20,37]. As was observed in pregnancy
[4], in the current study ERα were not detected by the
AER314 or AER311 antibody in the luminal epithelium of
heifers infused with IFN-τ. Together, these results suggest
that in the cow, like the ewe, IFN-τ may affect ERα
transcription.
Integrin αvβ3 mRNA and protein expression were high in
heifers receiving intrauterine infusions of estradiol. These
results confirm what we have observed in cycling animals
at estrus and suggest that at high levels following proges-
terone exposure, estrogen is a positive regulator of in-
tegrin αvβ3. Heifers infused with ICI 182, 870 also highly
expressed integrin αvβ3 on day 16. As an antagonist, ICI
182, 780 would prevent the characteristic downregulation
of integrin αvβ3 on cycle day 16 if endogenous follicular
estrogen was the mediator of the event. As an agonist, it
would upregulate endometrial ERα producing an estrus-
like uterine environment, which also would be associated
with high levels of integrin β3 gene expression. Whether
ICI 182, 780 acted as an antagonist or agonist with respect
to the integrin β3 gene thus cannot be distinguished. It is
clear that AER314-reactive ERα expression in the luminal
epithelium is not necessary for the cycle day 16 downreg-
ulation of the integrin, since both IFN-τ and ICI-182, 780
treated animals lacked this reactivity but only the former
showed the integrin downregulation. The role of estrogen
in this process remains to be determined. The promoter
region for bovine integrin subunit β3 has not been se-
quenced. While there are no estrogen response elements
in the avian, murine and human integrin subunit β3 pro-
moters, both have AP-1 and SP-1 binding sites [11,38,39].
Many examples exist of ER interacting with the AP-1 and
SP-1 transcription factors to confer estrogen responsive-
ness [40–42]. Alternatively, the transcription factor
HOXA10 has been shown to be upregulated in cultured
human endometrial cells in response to estrogen and pro-
gesterone and to regulate expression integrin subunit β3
mRNA [43,44]. Integrin αvβ3 regulation in the subepithe-
lial stroma is likely to involve an epithelial-stromal dia-
logue given that the cells of interest are in contact with the
basal lamina. In other species it has been shown that the
steroid responsiveness of epithelium and stroma is co-de-
pendent in endometrium [45].
Uterine infusion with IFN-τ did not prevent downregula-
tion of integrin αvβ3 in intercaruncular subepithelial stro-
ma on day 16 of the estrous cycle but did influence ERα in
the luminal epithelium. Clearly downregulation of in-
tegrin αvβ3 in the subepithelial stroma of cyclic animals is
not a necessary consequence of ERα changes in the lumi-
nal epithelium. Pregnancy does prevent downregulation
of integrin αvβ3 [10]. It is possible that the exposure peri-
od in this experiment was too brief to elicit expression of
epithelial or stromal interferon stimulated genes required
for maintenance of integrin αvβ3 in the subepithelial stro-
ma. Endogenous IFN-τ begins to be produced by
Figure 4
Effect of treatment onexpression of integrin subunit β3 as 
detected by Northern blot analysis of intercaruncular 
endometrium. A) Three animals were used in each treat-
ment group and received uterine infusions of either the saline 
control, interferon tau (IFN-τ), estrogen or ICI 182, 780. 
Thirty-five micrograms of total RNA from each animal were 
loaded per lane and biotin labeled riboprobes specific to 
integrin subunit β3 were used for hybridization to the mem-
brane. A single 2.4 kb transcript was detected. B) Least 
squares means ± standard error for integrin subunit β3 
mRNA band intensity by treatment (3 animals/treatment × 2 
replicate blots) were calculated using 18S as a covariate. 
Asterisks indicate means that are significantly different from 
the Control and IFN-τ (P < 0.05).
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trophoblast around day 12 [46], so pregnant animals
would have two additional days to respond to the com-
pound. After four days exposure to IFN-τ, the IFN-τ sign-
aling molecules, signal transduction and activation of
transcription 1 and 2, were observed in the subepithelial
stroma of cyclic ewes [47]. On the other hand, other tro-
phoblast factors or endometrial dialogue not induced by
treatment with IFN-τ may be necessary for integrin αvβ3
regulation.
To summarize, on day 16 of the estrous cycle both estro-
gen and ICI 182, 780 induced expression of ERα in the
endometrium and blocked the transient downregulation
of integrin αvβ3 on cycle day 16. Intrauterine infusion of
IFN-τ suppressed changes in ERα protein reactivity in the
luminal epithelium but did not affect integrin αvβ3 ex-
pression, suggesting IFN-τ may not prevent integrin αvβ3
downregulation during early pregnancy. We conclude that
on day 16 of the estrous cycle, estrogen effects on integrin
αvβ3 are indirect and do not directly involve ERα in the lu-
minal epithelium.
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